Global and China Bioburden Testing Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bioburden Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Instruments
1.2.3 Consumables
1.3 Market by Application
1.3.1 Global Bioburden Testing Market Share by Application: 2020 VS 2026
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 CMO
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bioburden Testing Market Perspective (2015-2026)
2.2 Global Bioburden Testing Growth Trends by Regions
2.2.1 Bioburden Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bioburden Testing Historic Market Share by Regions (2015-2020)
2.2.3 Bioburden Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioburden Testing Players by Market Size
3.1.1 Global Top Bioburden Testing Players by Revenue (2015-2020)
3.1.2 Global Bioburden Testing Revenue Market Share by Players (2015-2020)
3.2 Global Bioburden Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bioburden Testing Revenue
3.4 Global Bioburden Testing Market Concentration Ratio
3.4.1 Global Bioburden Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioburden Testing Revenue in 2019
3.5 Key Players Bioburden Testing Area Served
3.6 Key Players Bioburden Testing Product Solution and Service
3.7 Date of Enter into Bioburden Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioburden Testing Breakdown Data by Type (2015-2026)
4.1 Global Bioburden Testing Historic Market Size by Type (2015-2020)
4.2 Global Bioburden Testing Forecasted Market Size by Type (2021-2026)
5 Bioburden Testing Breakdown Data by Application (2015-2026)
5.1 Global Bioburden Testing Historic Market Size by Application (2015-2020)
5.2 Global Bioburden Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bioburden Testing Market Size (2015-2026)
6.2 North America Bioburden Testing Market Size by Type (2015-2020)
6.3 North America Bioburden Testing Market Size by Application (2015-2020)
6.4 North America Bioburden Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Bioburden Testing Market Size (2015-2026)
7.2 Europe Bioburden Testing Market Size by Type (2015-2020)
7.3 Europe Bioburden Testing Market Size by Application (2015-2020)
7.4 Europe Bioburden Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Bioburden Testing Market Size (2015-2026)
8.2 China Bioburden Testing Market Size by Type (2015-2020)
8.3 China Bioburden Testing Market Size by Application (2015-2020)
8.4 China Bioburden Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Bioburden Testing Market Size (2015-2026)
9.2 Japan Bioburden Testing Market Size by Type (2015-2020)
9.3 Japan Bioburden Testing Market Size by Application (2015-2020)
9.4 Japan Bioburden Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Bioburden Testing Market Size (2015-2026)
10.2 Southeast Asia Bioburden Testing Market Size by Type (2015-2020)
10.3 Southeast Asia Bioburden Testing Market Size by Application (2015-2020)
10.4 Southeast Asia Bioburden Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Charles River Laboratories International
11.1.1 Charles River Laboratories International Company Details
11.1.2 Charles River Laboratories International Business Overview
11.1.3 Charles River Laboratories International Bioburden Testing Introduction
11.1.4 Charles River Laboratories International Revenue in Bioburden Testing Business (2015-2020))
11.1.5 Charles River Laboratories International Recent Development
11.2 Sigma-Aldrich
11.2.1 Sigma-Aldrich Company Details
11.2.2 Sigma-Aldrich Business Overview
11.2.3 Sigma-Aldrich Bioburden Testing Introduction
11.2.4 Sigma-Aldrich Revenue in Bioburden Testing Business (2015-2020)
11.2.5 Sigma-Aldrich Recent Development
11.3 SGS
11.3.1 SGS Company Details
11.3.2 SGS Business Overview
11.3.3 SGS Bioburden Testing Introduction
11.3.4 SGS Revenue in Bioburden Testing Business (2015-2020)
11.3.5 SGS Recent Development
11.4 Wuxi Pharmatech (CAYMAN)
11.4.1 Wuxi Pharmatech (CAYMAN) Company Details
11.4.2 Wuxi Pharmatech (CAYMAN) Business Overview
11.4.3 Wuxi Pharmatech (CAYMAN) Bioburden Testing Introduction
11.4.4 Wuxi Pharmatech (CAYMAN) Revenue in Bioburden Testing Business (2015-2020)
11.4.5 Wuxi Pharmatech (CAYMAN) Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Bioburden Testing Introduction
11.5.4 Merck Revenue in Bioburden Testing Business (2015-2020)
11.5.5 Merck Recent Development
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Details
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson Bioburden Testing Introduction
11.6.4 Becton Dickinson Revenue in Bioburden Testing Business (2015-2020)
11.6.5 Becton Dickinson Recent Development
11.7 North American Science Associates Inc.
11.7.1 North American Science Associates Inc. Company Details
11.7.2 North American Science Associates Inc. Business Overview
11.7.3 North American Science Associates Inc. Bioburden Testing Introduction
11.7.4 North American Science Associates Inc. Revenue in Bioburden Testing Business (2015-2020)
11.7.5 North American Science Associates Inc. Recent Development
11.8 Nelson Laboratories
11.8.1 Nelson Laboratories Company Details
11.8.2 Nelson Laboratories Business Overview
11.8.3 Nelson Laboratories Bioburden Testing Introduction
11.8.4 Nelson Laboratories Revenue in Bioburden Testing Business (2015-2020)
11.8.5 Nelson Laboratories Recent Development
11.9 Pacific Biolabs
11.9.1 Pacific Biolabs Company Details
11.9.2 Pacific Biolabs Business Overview
11.9.3 Pacific Biolabs Bioburden Testing Introduction
11.9.4 Pacific Biolabs Revenue in Bioburden Testing Business (2015-2020)
11.9.5 Pacific Biolabs Recent Development
11.10 ATS Labs
11.10.1 ATS Labs Company Details
11.10.2 ATS Labs Business Overview
11.10.3 ATS Labs Bioburden Testing Introduction
11.10.4 ATS Labs Revenue in Bioburden Testing Business (2015-2020)
11.10.5 ATS Labs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Bioburden Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Instruments
Table 4. Key Players of Consumables
Table 5. Global Bioburden Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Bioburden Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Bioburden Testing Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Bioburden Testing Market Share by Regions (2015-2020)
Table 9. Global Bioburden Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Bioburden Testing Market Share by Regions (2021-2026)
Table 11. Bioburden Testing Market Market Trends
Table 12. Bioburden Testing Market Drivers
Table 13. Bioburden Testing Market Challenges
Table 14. Bioburden Testing Market Restraints
Table 15. Global Bioburden Testing Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Bioburden Testing Market Share by Players (2015-2020)
Table 17. Global Top Bioburden Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioburden Testing as of 2019)
Table 18. Global Bioburden Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bioburden Testing Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Bioburden Testing Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Bioburden Testing Market Size Share by Type (2015-2020)
Table 24. Global Bioburden Testing Revenue Market Share by Type (2021-2026)
Table 25. Global Bioburden Testing Market Size Share by Application (2015-2020)
Table 26. Global Bioburden Testing Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Bioburden Testing Market Size Share by Application (2021-2026)
Table 28. North America Bioburden Testing Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Bioburden Testing Market Share by Type (2015-2020)
Table 30. North America Bioburden Testing Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Bioburden Testing Market Share by Application (2015-2020)
Table 32. North America Bioburden Testing Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Bioburden Testing Market Share by Country (2015-2020)
Table 34. Europe Bioburden Testing Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Bioburden Testing Market Share by Type (2015-2020)
Table 36. Europe Bioburden Testing Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Bioburden Testing Market Share by Application (2015-2020)
Table 38. Europe Bioburden Testing Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Bioburden Testing Market Share by Country (2015-2020)
Table 40. China Bioburden Testing Market Size by Type (2015-2020) (US$ Million)
Table 41. China Bioburden Testing Market Share by Type (2015-2020)
Table 42. China Bioburden Testing Market Size by Application (2015-2020) (US$ Million)
Table 43. China Bioburden Testing Market Share by Application (2015-2020)
Table 44. China Bioburden Testing Market Size by Region (US$ Million) (2015-2020)
Table 45. China Bioburden Testing Market Share by Region (2015-2020)
Table 46. Japan Bioburden Testing Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Bioburden Testing Market Share by Type (2015-2020)
Table 48. Japan Bioburden Testing Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Bioburden Testing Market Share by Application (2015-2020)
Table 50. Japan Bioburden Testing Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Bioburden Testing Market Share by Country (2015-2020)
Table 52. Southeast Asia Bioburden Testing Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Bioburden Testing Market Share by Type (2015-2020)
Table 54. Southeast Asia Bioburden Testing Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Bioburden Testing Market Share by Application (2015-2020)
Table 56. Southeast Asia Bioburden Testing Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Bioburden Testing Market Share by Country (2015-2020)
Table 58. Charles River Laboratories International Company Details
Table 59. Charles River Laboratories International Business Overview
Table 60. Charles River Laboratories International Product
Table 61. Charles River Laboratories International Revenue in Bioburden Testing Business (2015-2020) (US$ Million)
Table 62. Charles River Laboratories International Recent Development
Table 63. Sigma-Aldrich Company Details
Table 64. Sigma-Aldrich Business Overview
Table 65. Sigma-Aldrich Product
Table 66. Sigma-Aldrich Revenue in Bioburden Testing Business (2015-2020) (US$ Million)
Table 67. Sigma-Aldrich Recent Development
Table 68. SGS Company Details
Table 69. SGS Business Overview
Table 70. SGS Product
Table 71. SGS Revenue in Bioburden Testing Business (2015-2020) (US$ Million)
Table 72. SGS Recent Development
Table 73. Wuxi Pharmatech (CAYMAN) Company Details
Table 74. Wuxi Pharmatech (CAYMAN) Business Overview
Table 75. Wuxi Pharmatech (CAYMAN) Product
Table 76. Wuxi Pharmatech (CAYMAN) Revenue in Bioburden Testing Business (2015-2020) (US$ Million)
Table 77. Wuxi Pharmatech (CAYMAN) Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Product
Table 81. Merck Revenue in Bioburden Testing Business (2015-2020) (US$ Million)
Table 82. Merck Recent Development
Table 83. Becton Dickinson Company Details
Table 84. Becton Dickinson Business Overview
Table 85. Becton Dickinson Product
Table 86. Becton Dickinson Revenue in Bioburden Testing Business (2015-2020) (US$ Million)
Table 87. Becton Dickinson Recent Development
Table 88. North American Science Associates Inc. Company Details
Table 89. North American Science Associates Inc. Business Overview
Table 90. North American Science Associates Inc. Product
Table 91. North American Science Associates Inc. Revenue in Bioburden Testing Business (2015-2020) (US$ Million)
Table 92. North American Science Associates Inc. Recent Development
Table 93. Nelson Laboratories Business Overview
Table 94. Nelson Laboratories Product
Table 95. Nelson Laboratories Company Details
Table 96. Nelson Laboratories Revenue in Bioburden Testing Business (2015-2020) (US$ Million)
Table 97. Nelson Laboratories Recent Development
Table 98. Pacific Biolabs Company Details
Table 99. Pacific Biolabs Business Overview
Table 100. Pacific Biolabs Product
Table 101. Pacific Biolabs Revenue in Bioburden Testing Business (2015-2020) (US$ Million)
Table 102. Pacific Biolabs Recent Development
Table 103. ATS Labs Company Details
Table 104. ATS Labs Business Overview
Table 105. ATS Labs Product
Table 106. ATS Labs Revenue in Bioburden Testing Business (2015-2020) (US$ Million)
Table 107. ATS Labs Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Bioburden Testing Market Share by Type: 2020 VS 2026
Figure 2. Instruments Features
Figure 3. Consumables Features
Figure 4. Global Bioburden Testing Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical Case Studies
Figure 6. Biotechnology Case Studies
Figure 7. CMO Case Studies
Figure 8. Bioburden Testing Report Years Considered
Figure 9. Global Bioburden Testing Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Bioburden Testing Market Share by Regions: 2020 VS 2026
Figure 11. Global Bioburden Testing Market Share by Regions (2021-2026)
Figure 12. Global Bioburden Testing Market Share by Players in 2019
Figure 13. Global Top Bioburden Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioburden Testing as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Bioburden Testing Revenue in 2019
Figure 15. North America Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Bioburden Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Charles River Laboratories International Revenue Growth Rate in Bioburden Testing Business (2015-2020)
Figure 43. Sigma-Aldrich Revenue Growth Rate in Bioburden Testing Business (2015-2020)
Figure 44. SGS Revenue Growth Rate in Bioburden Testing Business (2015-2020)
Figure 45. Wuxi Pharmatech (CAYMAN) Revenue Growth Rate in Bioburden Testing Business (2015-2020)
Figure 46. Merck Revenue Growth Rate in Bioburden Testing Business (2015-2020)
Figure 47. Becton Dickinson Revenue Growth Rate in Bioburden Testing Business (2015-2020)
Figure 48. North American Science Associates Inc. Revenue Growth Rate in Bioburden Testing Business (2015-2020)
Figure 49. Nelson Laboratories Revenue Growth Rate in Bioburden Testing Business (2015-2020)
Figure 50. Pacific Biolabs Revenue Growth Rate in Bioburden Testing Business (2015-2020)
Figure 51. ATS Labs Revenue Growth Rate in Bioburden Testing Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed